HOME >> BIOLOGY >> NEWS
Institute for OneWorld Health receives Gates Foundation grant

San Francisco, Calif. July 13, 2004 The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., announced today it has received a $1.4 million grant from the Bill & Melinda Gates Foundation to support development of a vaccine for the prevention and treatment of malaria, including for infants and children in the developing world.

Globally, more than 300 million cases of malaria occur annually and one million people, mostly children, die of the disease. Resistance to existing drugs and lack of both affordable and adequate treatments continue to make 40 percent of the world's population susceptible to malaria, especially in Africa, where a child dies every 30 seconds from the disease.

OneWorld Health has chosen to use part of its Gates Foundation grant to enter into a funded research arrangement with Sanaria Inc., a company that is developing a novel malaria vaccine. In addition to funding research and development activities, over the next 12 months, OneWorld Health will provide to Sanaria regulatory consulting and expertise on the project. This may include guidance in developing the quality assurance and quality control program for monitoring the manufacturing process, as well as planning for an Investigational New Drug (IND) application. Sanaria, based in Rockville, Md., will conduct various studies to confirm that key vaccine components can be produced with the ultimate goal of meeting U.S. Food and Drug Administration requirements.

Various independent studies conducted from the early 1970s through the late 1990s showed that exposure of human volunteers to the bites of mosquitoes infected with weakened (attenuated) malaria parasites, called sporozoites, protected more than 90 percent of those volunteers against developing malaria for at least 10 months. However, until Sanaria was launched, little effort was made to develop a malaria vaccine based on this approach. Sanaria is applying its unique manuf
'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700
Institute for OneWorld Health
13-Jul-2004


Page: 1 2

Related biology news :

1. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
2. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
3. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
4. Institute for OneWorld Health nominated for the 2004 World Technology Awards
5. UNC researchers awarded $8.65 million from National Institute on Aging
6. Lupus Research Institute awards $3 million in novel research grants to further new science in lupus
7. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
8. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
9. Institute for OneWorld Health CEO advocates focus first on developing world markets
10. Institute for Systems Biology, Pacific Northwest National Laboratory announce collaboration
11. Harvard Stem Cell Institute hosts inaugural symposia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/15/2018)... ... September 14, 2018 , ... Today, Mediaplanet announces the ... innovative work being done within rare diseases research, diagnostics, and will highlight what ... rare diseases. , The print component of "Rare Diseases" is ...
(Date:9/12/2018)... Minn. (PRWEB) , ... September 11, 2018 , ... ... wall coatings, is proud to introduce the new ChemXP™ line of high performance ... environments. The line was developed to provide Tennant Coatings’ elite certified installers with ...
(Date:9/12/2018)... ... 12, 2018 , ... Captiva Spine, Inc., which designs, manufactures ... 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market TowerLOX-EXT® ... TowerLOX-EXT MIS Extended Tab Pedicle Screws provide the narrow insertion of an extended ...
Breaking Biology News(10 mins):
(Date:9/7/2018)... ... September 06, 2018 , ... The Discovery on ... meeting of “The industry’s preeminent event on novel drug targets.” BellBrook Labs’ high ... to study these emerging targets in a quest to find new treatments for ...
(Date:8/31/2018)... ... 2018 , ... A recent expedition led by Dr. Blair ... of Industrial Science, the University of Tokyo, demonstrated how the use of autonomous ... of hard to reach deep sea ecosystems, like intermittently active methane seeps. Thanks ...
(Date:8/29/2018)... ... 2018 , ... CEO and founder of VetStem Biopharma, Dr. ... an allogeneic (donor derived) stem cell product for osteoarthritis in canines at the ... He is also the organizer of Breakout Session 4: Practitioner Primer on FDA ...
(Date:8/23/2018)... RENO/TAHOE, Nev. (PRWEB) , ... August 22, 2018 ... ... TrialKit ™ for Android on September 1st, making it the first fully-featured ... both iOS and Android devices. Combined, iOS and Android constitute 99 percent of ...
Breaking Biology Technology:
Cached News: